Abstract-Prehypertension is a highly frequent condition associated with an increased cardiovascular risk. Endothelial dysfunction is thought to promote the development of hypertension and vascular disease; however, underlying mechanisms remain to be further determined. The present study characterizes for the first time the in vivo endothelial repair capacity of early endothelial progenitor cells (EPCs) in patients with prehypertension/hypertension and examines its relation with endothelial function. Early EPCs were isolated from healthy subjects and newly diagnosed prehypertensive and hypertensive patients (nϭ52). In vivo endothelial repair capacity of EPCs was examined by transplantation into a nude mouse carotid injury model. EPC senescence was determined (RT-PCR of telomere length). NO and superoxide production of EPCs were measured using electron spin resonance spectroscopy analysis. CD34 ϩ /KDR ϩ mononuclear cells and circulating endothelial microparticles were examined by fluorescence-activated cell sorter analysis. Endothelium-dependent and -independent vasodilations were determined by high-resolution ultrasound. In vivo endothelial repair capacity of EPCs was substantially impaired in prehypertensive/hypertensive patients as compared with healthy subjects (re-endothelialized area: 15Ϯ3%/13Ϯ2% versus 28Ϯ3%; PϽ0.05 versus healthy subjects). Senescence of EPCs in prehypertension/hypertension was substantially increased, and NO production was markedly reduced. Moreover, reduced endothelial repair capacity of early EPCs was significantly related to an accelerated senescence of early EPCs and impaired endothelial function. The present study demonstrates for the first time that in vivo endothelial repair capacity of early EPCs is reduced in patients with prehypertension and hypertension, is related to EPC senescence and impaired endothelial function, and likely represents an early event in the development of hypertension. (Hypertension. 2010;55:1389-1397.)
P rehypertension is a highly frequent condition affecting Ϸ30% of the adult US population and has been defined as a systolic blood pressure range between 120 and 139 mm Hg and/or a diastolic blood pressure range between 80 and 89 mm Hg. 1, 2 Prehypertension is thought to be a precursor of stage 1 hypertension, a concept that has been further supported by the observations of the Trial of Preventing Hypertension, demonstrating that treatment of prehypertension with the angiotensin-receptor blocker candesartan prevented and postponed the development of hypertension even 2 years after the termination of active treatment. 3 Importantly, prehypertension is associated with a significantly increased cardiovascular risk. 4 Endothelial dysfunction is thought to be critical in the development of vascular disease. 5, 6 Of note, Taddei et al 7 have observed an abnormal endothelium-dependent vasodilation in the offspring of patients with essential hypertension, suggesting that endothelial dysfunction may promote the development of hypertension. Moreover, Schlaich et al 8 have demonstrated recently that individuals with a positive family history of hypertension had an abnormal L-arginine uptake, further supporting the concept that an alteration of endothelial function may contribute to the development of essential hypertension.
Notably, recent experimental studies have suggested that endothelial progenitor cells (EPCs) promote endothelial in-tegrity. 9 -11 At present, there are in particular 2 populations of EPCs differentiated based on their appearance in culture, that is, "early" EPCs appearing after 4 to 7 days, similar to those originally described by Asahara et al, 12 and "late" EPCs, appearing after 14 to 21 days. 13, 14 A beneficial effect on endothelial repair after injury has, in particular, been shown for early EPCs. 9 -11,15,16 Early EPCs have also been termed "circulating angiogenic cells," and are thought to exert their effects in particular by paracrine mechanisms. 14, 17 Furthermore, a relation between the number of in vitro formed colony forming units of early EPCs and endotheliumdependent vasodilation has been suggested. 18 However, it remains unclear whether in vivo endothelial repair capacity of early EPCs is altered in patients with prehypertension or hypertension and is related to an abnormal endotheliumdependent vasodilation and senescence.
In the present study, we have, therefore, examined in vivo endothelial repair capacity of early EPCs in prehypertensive and hypertensive patients as compared with healthy subjects (HSs) and analyzed the relationship with endotheliumdependent vasodilation and senescence. Importantly, patients included in the present study had newly diagnosed prehypertension or hypertension as their only cardiovascular risk factor. Moreover, early EPC senescence, as detected by telomere length and senescence-associated ␤-galactosidase (SA-␤-Gal) staining analysis, and NO and superoxide production, as determined by electron spin resonance (ESR) spectroscopy analysis, were examined to understand potential mechanisms leading to an altered early EPC in vivo endothelial repair capacity. In addition, EPC numbers and endothelial apoptotic microparticles (CD31 ϩ /Annexin V ϩ particles) were determined by fluorescence-activated cell sorter (FACS) analysis.
Methods
Written informed consent was obtained from all of the participants, and the study protocol has been approved by the local ethics committee. We screened 130 nonsmoking volunteers, aged between 40 and 70 years, without known cardiovascular disease or ongoing pharmacological therapies. HSs were included when they had no cardiovascular risk factors, a systolic blood pressure Ͻ120 mm Hg, and a diastolic blood pressure Ͻ80 mm Hg (see below). Patients with prehypertension (systolic blood pressure between 120 and 139 mm Hg) or hypertension (systolic blood pressure Ն140 mm Hg) were included when they had no other cardiovascular risk factors. In particular, subjects with obesity (body mass index: Ͼ30), hypercholesterolemia (low-density lipoprotein Ͼ160 mg/dL or total cholesterol Ͼ240 mg/dL), positive family history for cardiovascular disease, diabetes mellitus, renal impairment, or known cardiovascular disease were excluded. Patients with newly diagnosed hypertension were without pharmacological therapy. Blood pressure measurements were performed according to the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure/European Society of Cardiology 2007 recommendations, that is, all of the subjects underwent Ն3 blood pressure measurements in 2 different visits, after 20 to 30 minutes of rest, and the measurements were spaced by 5-to 10-minute intervals, on both the left and right arm, in the sitting and lying positions. Furthermore, all of the participants underwent a 24-hour blood pressure measurement. Methodological details for the performed analyses, that is, characterization of early EPCs and endothelial function, are provided in the online Data Supplement (please see http://hyper.ahajournals.org).
Results

Characteristics of HSs and Patients With Prehypertension and Hypertension
The characteristics of HSs and patients with prehypertension or hypertension are shown in Table 1 . Notably, newly diagnosed prehypertensive and hypertensive patients were included in the present study when they did not have other cardiovascular risk factors. Moreover, no patients had to be excluded because of white coat effects, because in all of the enrolled patients the office blood pressure values were confirmed by 24-hour blood pressure measurements.
Detection of Homing of Early EPCs to Injured Carotid Artery by FACS Analysis
Previous studies have suggested that mesenchymal stem cells have a very limited capacity to reach the carotid artery after intravenous injection, that is, likely a low pulmonary passage. 19 In order to examine whether the intravenously injected early EPCs is home to the injured carotid artery, early EPCs from healthy subjects were stained with carboxyfluoresceindiacetate-succinimidyl-ester and injected into the tail vein of nude mice with carotid injury (2ϫ10 5 cells). After 24 hours, the injured and the corresponding sections of the uninjured contralateral carotid artery were homogenized, and the number of labeled EPCs was quantified by using FACS analysis. As shown in Figure 1A , a significant homing of labeled early EPCs was observed in the injured but not in the uninjured carotid artery. To further examine the localization of labeled early EPCs in the carotid artery, confocal laser scanning microscopy was performed.
Detection of Homing of Early EPCs to Injured Carotid Artery by Confocal Laser Scanning Microscopy Analysis
Confocal laser scanning microscopy analysis was used to obtain selective images with increasing depth of the carotid arteries. TAMRA (5-carboxytetramethylrhodamine)-labeled early EPCs (red signal) were detected in the endothelial repair zone of the injured carotid artery but not in the uninjured carotid artery after injection into the tail vein of nude mice with carotid injury ( Figure 1B ). Fluorescence-labeled early EPCs were localized immediately beneath the endothelial layer, as indicated by serial imaging with increasing depth by using confocal laser scanning microscopy analysis of the re-endothelialized zone of the carotid artery ( Figure 1B ).
In Vivo Endothelial Repair Capacity of Early EPCs
Transplantation of early EPCs from HSs markedly accelerated endothelial repair (Figure 2A and 2B). Notably, in vivo endothelial repair capacity of early EPCs from patients with prehypertension and hypertension was markedly reduced as compared with that in HSs ( Figure 2A ). Representative photographs of repaired endothelium 3 days after transplantation of early EPCs from the 3 different study groups are shown in Figure 2B . The number of early EPCs was similar after 4-day culture in the 3 groups (159Ϯ15ϫ10 6 /cm 2 in HSs versus 179Ϯ27ϫ10 6 /cm 2 in prehypertensives versus 149Ϯ15ϫ10 6 / cm 2 in hypertensives; P value not significant).
Endothelium-Dependent and Endothelium-Independent Vasodilation
Flow-dependent, endothelium-mediated vasodilation (FMD) was markedly reduced in prehypertensive patients as compared with HSs (FMD: 11.6Ϯ0.7% versus 8.8Ϯ0.7%; Pϭ0.01; Figure  2C ). FMD was further impaired in hypertensive patients (6.5Ϯ0.5%; PϽ0.01 versus prehypertensive; Figure 2C ). There was no significant difference in the radial artery diameter between the groups (Table 2) . Arterial blood flow measurements were performed to determine whether a reduced increase of arterial blood flow during reactive hyperemia could explain the impaired FMD observed in patients with prehypertension or hypertension. As shown in Table 2 , the values for arterial blood flow in response to reactive hyperemia in patients with prehypertension or hypertension were not lower as compared with HSs, thereby rather excluding a reduced arterial blood flow response under reactive hyperemia as a mechanism that could explain the impaired endothelium-dependent vasodilation observed in prehypertensive and hypertensive patients. Moreover, there were no differences in endothelium-independent relaxation of the radial artery among the 3 groups, suggesting a specifically impaired from HSs were stained with carboxyfluorescein-diacetate-succinimidylester and injected into the tail vein of nude mice with carotid injury. After 24 hours, the injured and the corresponding section of the contralateral uninjured carotid artery were homogenized, and the number of labeled EPCs was quantified by using FACS analysis (nϭ3). B, Confocal laser scanning microscopy analysis (magnification: ϫ200) of the injured and uninjured carotid arteries. TAMRA-labeled early EPCs (red signal) were injected into the tail vein of nude mice with carotid injury. Confocal laser scanning microscopy analysis was used to obtain selective images with increasing depth. First, the endothelial layer was visualized by whole-mount CD31 immunostaining (green) of the uninjured (I) and injured (II; endothelial repair zone) carotid artery, and 4Ј,6-diamidino-2-phenylindole staining (mounting medium) was used for nuclei staining (blue). Fluorescencelabeled early EPCs (TAMRA; red signal) were located beneath the endothelial layer, as indicated by repeated serial imaging with increasing depth by confocal laser scanning microscopy analysis of the re-endothelialized zone of the carotid artery (III and IV). In the subendothelial layer of the endothelial repair zone of the carotid artery, fluorescence-labeled early EPCs (red signal) were clearly detectable (V).
endothelium-dependent vasodilation in prehypertensive and hypertensive patients (Table 2) .
Relation Between Early EPC In Vivo Endothelial Repair Capacity and FMD
In vivo endothelial repair capacity of early EPCs was positively related to FMD (rϭ0.38; PϽ0.05; Figure 2D ), suggesting that impaired early EPC-mediated endothelial repair capacity is related to a reduced endothelium-dependent vasodilation. Figure 3A ) as compared with HSs. As a second marker of early EPC senescence, the acidic SA-␤-Gal staining of early EPCs was examined. SA-␤-Gal-positive early EPCs were significantly increased in prehypertensive and hypertensive patients as compared with HSs ( Figure 3B ). Moreover, there was a significant positive relationship between early EPC telomere length and early EPC in vivo endothelial repair capacity (rϭ0.31; PϽ0.05; Figure 3C ). Similarly, as evaluated by SA-␤-Gal staining, early EPC senescence was inversely related to early EPC in vivo endothelial repair capacity (rϭϪ0.30; PϽ0.05; Figure 3D ), suggesting that impaired early EPC senescence is associated with an impaired in vivo endothelial repair capacity of early EPCs. Notably, early EPC telomere length was inversely related to systolic blood pressure values (rϭ0.69; PϽ0.05; Figure 3E ). In addition, the analysis of telomerase activity in a subgroup of prehypertensive and hypertensive patients revealed a markedly reduced telomerase activity in early EPCs from these patients as compared with early EPCs from HSs (HSs versus prehypertensive/hypertensive patients: 24.2Ϯ3.4% versus 15.8Ϯ1.9%; nϭ12; PϽ0.05).
Early EPC Senescence as Examined by Telomere Length and SA-␤-Gal Staining
Early EPC NO and Superoxide Production
Early EPC NO production and oxidative stress have been suggested to play an important role for EPC repair capacity. Early EPC NO and superoxide production were, therefore, examined by ESR spectroscopy analysis. NO production was significantly reduced in early EPCs from prehypertensive/ hypertensive patients as compared with HSs (474Ϯ28 versus 376Ϯ23 pmol/60 minutes; Pϭ0.01; nϭ13 to 18; Figure 4A ). There was no significant difference in early EPC superoxide production between prehypertensive/hypertensive patients and HSs ( Figure 4B ).
FACS Analysis of the Number of Circulating CD34
؉
/KDR ؉ Mononuclear Cells
We did not observe a significant difference in the numbers of circulating CD34/KDR double-positive mononuclear cells between newly diagnosed prehypertensive/hypertensive patients and HSs ( Figure 5A ).
FACS Analysis of Circulating Endothelial Apoptotic Microparticles
The number of circulating endothelial apoptotic microparticles was not significantly different between newly diagnosed prehypertensive/hypertensive patients and HSs ( Figure 5B ). [kb]
Early EPC Telomere Length 
Discussion
The present study demonstrates for the first time that in vivo endothelial repair capacity of early EPCs is substantially impaired in patients with newly diagnosed prehypertension and hypertension as their only cardiovascular risk factor. Moreover, increased senescence of early EPCs as indicated by telomere shortening and increased SA-␤-Gal staining in prehypertensive and hypertensive patients was related to impaired EPC in vivo endothelial repair capacity. In addition, NO production as determined by ESR spectroscopy was substantially reduced in early EPCs derived from prehypertensive and hypertensive patients, providing a further potential underlying mechanism leading to reduced endothelial repair capacity of early EPCs in these patients. Importantly, the present study provides the first evidence that reduced in vivo endothelial repair capacity of early EPCs is related to impaired endothelium-dependent vasodilation. We did not observe a significant difference in the number of circulating EPCs (as assessed by CD34/KDR double-positive mononuclear cells) and endothelial apoptotic microparticles in prehypertensive and hypertensive patients as compared with
HSs. These findings suggest that impaired in vivo endothelial repair capacity of early EPCs related to senescence and a reduced endothelium-dependent vasodilation represents an early event in the development of hypertension. Endothelial dysfunction is thought to promote the development of vascular disease and hypertension. 5, 6, 20 The present study provides novel evidence indicating that the in vivo endothelial repair capacity of early EPCs, as determined by transplantation of early EPCs into nude mice with vascular injury, is markedly impaired in prehypertensive and hypertensive patients without other cardiovascular risk factors. Moreover, impaired in vivo endothelial repair capacity of early EPCs was related to increased senescence of EPCs and an impaired endothelium-dependent vasodilation, suggesting that a reduced in vivo repair capacity of EPCs is an early event in the development of hypertension and vascular disease. Although these findings do not prove a cause-andeffect relationship, there is evidence to suggest that impaired early EPC repair capacity may contribute to endothelial dysfunction. In a preclinical study, Wassmann et al 21 have observed that infusion of circulating early EPCs was able to augment endothelium-dependent vasodilation. Moreover, interventions that augment early EPC function, such as statin therapy or physical exercise, are associated with improved endothelial function. [22] [23] [24] In addition, Hill et al 18 have reported an inverse relation between the in vitro obtained number of EPC colony-forming units from circulating mononuclear cells and the degree of endothelial dysfunction. Importantly, Murasawa et al 25 have observed recently that overexpression of human telomerase reverse transcriptase in early EPCs increased their migratory activity and postnatal neovascularization capacity, suggesting that senescence and telomerase activity are important factors regulating EPC function. In the present study, we have characterized EPC senescence in prehypertensive and hypertensive patients and its relation to EPC endothelial repair capacity. Notably, both measurements of telomere length and SA-␤-Gal staining indicated an increased senescence of early EPCs from prehypertensive and hypertensive subjects that was related to an impaired in vivo endothelial repair capacity of early EPCs. In addition, our ESR spectroscopy measurements revealed a reduced NO bioavailability in EPCs derived from prehypertensive/hypertensive patients. Notably, several recent studies, including work from our own group, have indicated that endothelial NO synthase is critical for EPC function and that early EPC endothelial repair capacity is reduced as a consequence of reduced NO production in early EPCs. 10, 26 Moreover, lack of endothelial NO synthase has been shown to reduce basal telomerase activity in endothelial cells that was restored by exogenous endothelial NO synthase or an NO donor, thus suggesting that a reduced NO availability may contribute to reduced telomerase activity. 27 Notably, previous studies have indicated that mesenchymal stem cells have a very limited transpulmonary passage to the carotid artery after intravenous injection. 19 We have, therefore, performed studies to determine whether human early EPCs can be detected in the injured carotid artery after intravenous injection. After intravenous injection of labeled human early EPCs, we could detect by both (ie, FACS analyses of homogenized carotid arteries and confocal laser scanning microscopy analyses) an increased homing of early EPCs to the injured carotid artery but not to the contralateral uninjured carotid artery. One likely explanation for the observed homing of early EPCs in the injured carotid artery after intravenous injection in the present study is that these cells are substantially smaller in size as compared with mesenchymal stem cells as studied by Fischer et al. 19 Indeed, Fischer et al 19 have observed recently that bone marrowderived mononuclear cells, likely in size more similar to early EPCs, have a 30-fold higher pulmonary passage, as detected in the carotid artery after intravenous injection as compared with mesenchymal stem cells.
Furthermore, our confocal laser scanning microscopy analyses suggested that the injected early EPCs can be detected in the subendothelial space of the endothelial repair zone of the injured carotid artery, suggesting that these cells promote the endothelial repair process likely in particular by paracrine mechanisms. These observations are in line with a recent study by Schroeter et al 16 that detected by fluorescence microscopy a subendothelial homing of intravenously injected early EPCs, promoting the endothelial repair response in another model of carotid injury. Moreover, these observations are consistent with a recent study by Sieveking et al 17 suggesting that early EPCs promote the proangiogenic effects largely in a paracrine fashion. Therefore, the findings of the present study in context with previous findings suggest that the stimulation of the in vivo endothelial repair response by early EPCs is likely largely mediated by paracrine effects.
Endothelial damage is likely characterized by an imbalance of endothelial cell growth/repair and the loss of endothelial cells, that is, by apoptosis. 28 In the present study we, therefore, determined the number of circulating CD34 ϩ / KDR ϩ and cultured early EPCs, as well as the number of circulating endothelial apoptotic microparticles. We did not observe a significantly reduced number of cultured early EPCs or CD34 ϩ /KDR ϩ cells as determined by FACS analysis. However, an important difference of the present study as compared with previous studies that have examined the number of CD34 ϩ /KDR ϩ cells or cultured early EPCs in patients with established cardiovascular disease and cardiovascular risk factors is that in the present study only patients with newly diagnosed prehypertension/hypertension without other cardiovascular risk factors or known cardiovascular disease were included. Notably, if one looks closely at the results of previous studies, for example, by Vasa et al, 29 the number of early EPCs (as determined both by the number of CD34 ϩ /KDR ϩ cells or cultured early EPCs) was not different for patients who had only 1 cardiovascular risk factor as compared with control subjects but was substantially reduced in patients with several cardiovascular risk factors. Furthermore, in the study by Vasa et al, 29 hypertensive patients did not have a lower number of early EPCs as compared with patients without hypertension. In line with these findings are observations from a recent study by Werner et al 30 that evaluated the prognostic value of CD34 ϩ /KDR ϩ cell numbers for the development of cardiovascular events in patients with coronary artery disease. In a subgroup of 432 coronary artery disease patients with arterial hypertension, there was no association between the number of CD34 ϩ /KDR ϩ cells and arterial hypertension. Moreover, a recent study by Delva et al 31 examined the number of cultured early EPCs in 36 patients with essential hypertension and 24 control subjects and did not report a reduced number of cultured early EPCs in hypertensive patients. However, in patients with advanced and refractory hypertension, EPC numbers were reduced in a recent study by Oliveras et al. 32 Therefore, the observations of the present study in the context of previous findings are consistent with the notion that the dysfunction of early EPCs is rather substantially more pronounced and begins earlier as compared with a detectable reduction of the number of circulating early EPCs in patients with hypertension. Importantly, the present study provides for the first time evidence that the in vivo re-endothelialization capacity of early EPCs is already profoundly reduced in patients with prehypertension and is related to impaired endothelium-dependent vasodilation and senescence of early EPCs. Notably, whereas endothelium-dependent vasodilation was more profoundly reduced in patients with hypertension as compared with prehypertension, the endothelial repair capacity of early EPCs was already profoundly impaired in prehypertension, which is in line with the above notion, that the functional impairment of early EPCs is likely an early event in the development of hypertension.
In the present study, no increase of circulating endothelial apoptotic microparticles was observed in prehypertensive or
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hypertensive patients. Notably, Preston et al 33 have observed an increased number of circulating endothelial apoptotic microparticles in severely hypertensive patients. Werner et al 34 have recently reported a relation between endothelial dysfunction and the degree of endothelial cell apoptosis, as measured by circulating CD31/Annexin V ϩ endothelial apoptotic microparticles in patients with established coronary disease. Therefore, the results of the present study, together with previous observations, suggest that a detectable increase of circulating endothelial apoptotic microparticles is likely occurring in a more advanced stage of hypertension or in patients with established cardiovascular disease.
Limitations of the Study
Different methods are in use to isolate and culture EPCs. 14 At least 2 populations have been commonly differentiated, that is, early EPCs and late outgrowth EPCs obtained after several weeks of culture, as pointed out recently. 13, 17 We have examined in the present study the endothelial repair capacity of early EPCs. Given that early EPCs are rather more frequent in number, they may play a particularly important role for the stimulation of endothelial repair processes. Furthermore, because of a substantial variation in the FACS-determined number of CD34 ϩ /KDR ϩ cells and with respect to the group sizes of the present study, conclusions with respect to the numbers of EPCs as determined by FACS analysis need to be interpreted with caution. Given that there was, however, rather a trend for increased numbers of CD34 ϩ /KDR ϩ cells in prehypertension/hypertension, the present data suggest that the number of these cells is likely not reduced in newly diagnosed prehypertensive/hypertensive patients without other cardiovascular risk factors or known cardiovascular disease and that the functional impairment of early EPCs with respect to their endothelial repair capacity is likely substantially more pronounced in this early stage of the disease.
Perspectives
Endothelial dysfunction is thought to contribute to the development of hypertension and atherosclerotic vascular disease, however, the underlying mechanisms are incompletely understood. The present study provides novel evidence suggesting that in vivo endothelial repair capacity of early EPCs, likely largely mediated by paracrine effects, is markedly reduced in patients with prehypertension and hypertension and is related to the impairment of endothelial function. These findings indicate that an impaired endothelial repair capacity of EPCs is an early event in the development of hypertension and vascular disease and raise the possibility that interventions to preserve endothelial repair capacity of EPCs, for example, by inhibition of their accelerated senescence and reduced NO availability, may represent an attractive novel approach to stimulate endogenous endothelial repair responses and potentially to prevent endothelial dysfunction and the development and progression of vascular disease.
